<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Diagnostic tests for cytomegalovirus*</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Diagnostic tests for cytomegalovirus*</h1>
<div class="graphic"><div class="figure"><div class="ttl">Diagnostic tests for cytomegalovirus*</div><div class="cntnt"><table cellspacing="0"><colgroup width="20%"></colgroup><colgroup span="6" width="13%"></colgroup> <tbody> <tr> <td class="subtitle1"> </td> <td class="subtitle1">Serology</td> <td class="subtitle1">Quantitative PCR<sup>¶</sup></td> <td class="subtitle1">Antigenemia<sup>Δ</sup></td> <td class="subtitle1">Culture</td> <td class="subtitle1">Histopathology<sup>◊</sup></td> <td class="subtitle1">Resistance testing</td> </tr> <tr> <td class="subtitle2_left" colspan="7">Immunocompetent</td> </tr> <tr> <td class="indent1">Acute or recent infection</td> <td>IgM or fourfold increase of IgG</td> <td>Plasma or whole blood</td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr> <td class="indent1">Past infection</td> <td>IgG</td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr class="divider_bottom"> <td class="indent1">Critically ill</td> <td> </td> <td>Plasma or whole blood; consider BAL</td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr> <td class="subtitle2_left" colspan="7">Immunocompromised</td> </tr> <tr> <td class="indent1">Assessing risk of CMV disease</td> <td>IgG</td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr> <td class="indent1">Diagnosis of disease</td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr> <td class="indent2">Viral syndrome</td> <td> </td> <td>Plasma or whole blood</td> <td>PBMCs</td> <td> </td> <td> </td> <td> </td> </tr> <tr> <td class="indent2">Pneumonitis</td> <td> </td> <td>Plasma or whole blood; consider BAL</td> <td>PBMCs</td> <td>BAL or lung tissue</td> <td>BAL or lung tissue</td> <td> </td> </tr> <tr> <td class="indent2">Gastrointestinal disease</td> <td> </td> <td>Plasma or whole blood<sup>§</sup></td> <td>PBMCs<sup>§</sup></td> <td>Tissue</td> <td>Tissue</td> <td> </td> </tr> <tr> <td class="indent2">Central nervous system disease</td> <td> </td> <td>CSF, plasma, whole blood</td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr> <td class="indent2">Retinitis</td> <td> </td> <td>Vitreous or aqueous fluid</td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr> <td class="indent1">Decisions regarding preemptive therapy</td> <td> </td> <td>Plasma or whole blood</td> <td>PBMCs</td> <td> </td> <td> </td> <td> </td> </tr> <tr> <td class="indent1">Monitoring response to therapy</td> <td> </td> <td>Plasma or whole blood</td> <td>PBMCs</td> <td> </td> <td> </td> <td> </td> </tr> <tr> <td class="indent1">Treatment failure</td> <td> </td> <td>Plasma or whole blood</td> <td>PBMCs</td> <td> </td> <td> </td> <td>Yes</td> </tr> </tbody></table></div><div class="graphic_footnotes">PCR: polymerase chain reaction; IgM: immunoglobulin M; IgG: immunoglobulin G; BAL: bronchoalveolar lavage; CMV: cytomegalovirus; CSF: cerebrospinal fluid; PBMCs: peripheral blood polymorphonuclear leukocytes.<br/>* Refer to the UpToDate topic reviews on diagnosis of CMV for detailed recommendations regarding the use of these assays. This table does not address diagnostic testing for CMV infection in neonates with congenital or perinatal CMV infection. For details on diagnostic testing in newborns, refer to the UpToDate table on laboratory tests for the detection of CMV in neonates with suspected congenital infection and topic reviews on congenital and perinatal CMV infection.<br/>¶ Quantitative PCR assays offer several advantages over the antigenemia assay, including better assay standardization, increased stability of the specimen, smaller specimen volume, and the ability to test patients with leukopenia. For these reasons, quantitative PCR assays are more widely used than the antigenemia test, and we prefer them for the diagnosis and monitoring of immunocompromised patients with CMV infection and disease.<br/>Δ The CMV antigenemia assay is insensitive when the patient has a low neutrophil count (&lt;1000 cells/microL).<br/>◊ This includes histopathology and immunohistochemical staining.<br/>§ Negative results are common with gastrointestinal disease.</div><div id="graphicVersion">Graphic 101937 Version 2.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
